Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficacy of ivermectin and its metabolites against Plasmodium falciparum liver stages in primary human hepatocytes

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01272-23Source: DataRank Database

Efficacy of ivermectin and its metabolites against Plasmodium falciparum liver stages in primary human hepatocytes is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.61)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Phornpimon Tipthara ORCID,Surendra Kumar Kolli ORCID,Justin Nicholas,Samantha J. Barnes ORCID,Madison M. Ogbondah

Live enrichment

PubMed:38904389 PMC:PMC11304735 OpenAlex:https://openalex.org/W4399889350

HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases

Grant: R21AI149730

HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases

Grant: R01AI117017

FWCI

0.61

Citation Percentile

0.7%

Citation Trend

2024

2025

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11304735/pdf/aac.01272-23.pdf

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.01272-23

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11304735

journalhttps://doi.org/10.1128/aac.01272-23

Fields of Study

Parasitic Diseases Research and TreatmentParasites and Host InteractionsParasite Biology and Host InteractionsIvermectinHepatocytesHumansPlasmodium falciparumCytochrome P-450 CYP3AAntimalarialsLiverMalaria, FalciparumAnimalsCells, CulturedAnopheles

MeSH Terms

AnimalsAnophelesAntimalarialsCells, CulturedHumansIvermectinLiverPlasmodium falciparumMalaria, FalciparumHepatocytesCytochrome P-450 CYP3A

Keywords

Plasmodium falciparumIvermectinBiologyAntiparasitic agentMalariaMicrobiologyVirologyPharmacologyImmunologyZoologyPlasmodiumDrug metabolismLiver StageCytochrome P450 Cyp3a4

Sustainable Development Goals

SDG 0: Good health and well-being